For therapeutic aspects, we performed differential analysis of GNG5 expression with different antitumor agents and found that many chemotherapeutic agents or targeted agents may inhibit high-risk hepatocellular carcinoma at relatively small doses. The gene discussed is GNG5; the disease is hepatocellular carcinoma.